To improve the website's functionality, we use cookies, including third-party cookies. Read our Privacy Policy for more information
I AgreeAnalysis of Biomimetic Peptides market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Biomimetic peptides is a novel product launched in the ingredients market and has shown positive reaction in the initial years. Showcased for their application in cosmetics and pharmaceuticals for increasing the efficacies of the products, the biomimetic peptides have shown growing adoption in the personal care industry. With increased demand for cosmetic additives in the market, biomimetic peptides are expected to gain significant traction. On the backdrop of increasing demand for personal care products, and increasing adoption of additives in cosmetics, market for biomimetic peptides is expected to show significant growth during the forecast period.
With more than 8% of geriatric population which is expected to increase during the coming years, demand for multiple cosmetics products is expected to increase. Anti-pigmentation and Anti-aging products are expected to gain significant traction due to this demand, which in turn is expected to drive the growth of the biomimetic peptides market.
With cosmetic manufacturers investing in research and development to gain edge over their competitors, companies have been experimenting with additives like biomimetic peptides. With proven increase in efficacy and positive studies for human usage, biomimetic peptides are expected to gain significant ground in the cosmetics additives market.
The Biomimetic Peptides market can be segmented on the basis of end use industry and application.
South Korea market cosmetics market being ahead of the curve in the cosmetics industry, biomimetic peptides have been prevalent in the market for multiple years. Adoption of biomimetic peptides in the European cosmetics market has been increasing and is expected to show significant growth during the coming years. Asia-Pacific accounts for larger share in the biomimetic peptides market, while Europe can be considered as emerging market. Stringent regulatory scenario in the European market regarding synthetic components has been one of the prominent hurdle in the adoption of biomimetic peptides in the region. North America is expected to be one of the prominent regions to explore for new entrants as well as emerging players in the market. Increasing adoption of South Korean products in the United States is also expected to benefit the growth of biomimetic peptides.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
Biomimetic Peptides is currents in the introduction stage and has multiple low level players in the market. Caregen Co., Ltd is one of the pioneers in the market with their product launched in 2002. Other prominent companies working in the biomimetic peptides market are Koninklijke DSM N.V., Swedish Biomimetics 3000, among others. Companies have been investing in increasing their offering and development of new manufacturing processes. In 2019, Swedish Biomimetics 3000 invented a trademarked manufacturing processes μLOT. Similar innovations are expected with increase in investments of the top companies. Investments in patents for these products and processes is expected to supplement the growth of the players in the market. The market is expected to see multiple new entrants in the market during coming years. The market is expected to move towards fragmentation on the global scale during the forecast period.
The overall demand for nutritional products in general has increased over the lockdown. The effect of the pandemic on the Biomimetic Peptides market is expected to be similar in the early stages. Determining the impact of Covid-19 on the demand for biomimetic peptides will be premature. Shutdown of manufacturing facilities are expected to significantly impact the sales of biomimetic peptides. The disruption in the supply chain is expected to have snowball effect on the market, and lead to supply and demand deficit. The global pandemic has thrown out many roadblocks for stable growth of global biomimetic peptides market. Effect of the pandemic is expected to be similar to cosmetics additives market.
The research report presents a comprehensive assessment of the Biomimetic Peptides market and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also includes projections using a suitable set of assumptions and methodologies. The research report of the Biomimetic Peptides market provides analysis and information according to the different market segments such as end use industry, application and region.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
The Biomimetic Peptides market report is a compilation of first-hand information, qualitative and competitive assessment industry analysts, and inputs from industry experts and industry participants across the value chain. The report for the Biomimetic Peptides market provides an in depth analysis of the parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunities
Pre BookGet A Special pricing for start-ups and universities
Enquiry Before Buying- Humble, Yet Honored -
Global sales of biomimetic peptides are expected to rise at a 6% CAGR during the forecast period.
There is high demand for biomimetic peptides from the cosmetics industry due to the global rising trend to look good.
Caregen Co., Ltd, Koninklijke DSM N.V., and Swedish Biomimetics 3000 are the top 3 producers of biomimetic peptides.